BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23941005)

  • 1. Primary uterine cervical cancer: correlation of preoperative magnetic resonance imaging and clinical staging (FIGO) with histopathology findings.
    Kraljević Z; Visković K; Ledinsky M; Zadravec D; Grbavac I; Bilandzija M; Soljacić-Vranes H; Kuna K; Klasnić K; Krolo I
    Coll Antropol; 2013 Jun; 37(2):561-8. PubMed ID: 23941005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI-based radiomics features for the non-invasive prediction of FIGO stage in cervical carcinoma: A multi-center study.
    Liu Y; Dong TF; Li PJ; Chen LB; Song T
    Magn Reson Imaging; 2024 Jul; 110():170-175. PubMed ID: 38035947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study.
    Knoth J; Pötter R; Jürgenliemk-Schulz IM; Haie-Meder C; Fokdal L; Sturdza A; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Wiebe E; Rai B; Cooper R; van der Steen-Banasik E; van Limbergen E; Pieters BR; Sundset M; Tan LT; Nout RA; Tanderup K; Kirisits C; Nesvacil N; Lindegaard JC; Schmid MP
    Gynecol Oncol; 2020 Oct; 159(1):136-141. PubMed ID: 32798000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of the value of pre- and post-treatment magnetic resonance imaging examinations for advanced cervical cancer.
    Csutak C; Ordeanu C; Nagy VM; Pop DC; Bolboaca SD; Badea R; Chiorean L; Dudea SM
    Clujul Med; 2016; 89(3):410-8. PubMed ID: 27547062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study.
    Duan H; Li H; Kang S; Zhao H; Chen B; Wang L; Li P; Wang Y; Wang W; Lang J; Liu P; Chen C
    Acta Obstet Gynecol Scand; 2023 Aug; 102(8):1045-1052. PubMed ID: 37338046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of 3.0 T multimodal MRI in FIGO staging of cervical cancer.
    Pan L; Shan RY; Gao SF; Zhou Y; Bao YY; Fu W
    Technol Health Care; 2024; 32(2):823-830. PubMed ID: 37393459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical Cancer Histology, Staging and Survival before and after Implementation of Organised Cervical Screening Programme in Poland.
    Nowakowski A; Cybulski M; Buda I; Janosz I; Olszak-Wąsik K; Bodzek P; Śliwczyński A; Teter Z; Olejek A; Baranowski W
    PLoS One; 2016; 11(5):e0155849. PubMed ID: 27196050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COVID-19 on gynecological cancer incidence: a large cohort study in Japan.
    Komatsu H; Ikeda Y; Kawana K; Nagase S; Yoshino K; Yamagami W; Tokunaga H; Kato K; Kimura T; Aoki D; Obstetrics TCOGOOTJSO; Gynecology
    Int J Clin Oncol; 2024 Jan; 29(1):72-77. PubMed ID: 38055097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Imaging Evaluation of Endometrial Cancer in FIGO 2023.
    Kido A; Himoto Y; Kurata Y; Minamiguchi S; Nakamoto Y
    J Magn Reson Imaging; 2023 Dec; ():. PubMed ID: 38146775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and radiological stratification within FIGO 2018 stages improves risk-prediction in cervical cancer.
    Halle MK; Bozickovic O; Forsse D; Wagner-Larsen KS; Gold RM; Lura NG; Woie K; Bertelsen BI; Haldorsen IS; Krakstad C
    Gynecol Oncol; 2024 Feb; 181():110-117. PubMed ID: 38150835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Update on the Role of MRI in Treatment Stratification of Patients with Cervical Cancer.
    Shakur A; Lee JYJ; Freeman S
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience.
    Sofic A; Husic-Selimovic A; Beslic N; Rasic A; Begic D; Tomic-Cica A; Imsirevic N
    Acta Inform Med; 2017 Mar; 25(1):39-43. PubMed ID: 28484296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reviewing FIGO 2018 cervical cancer staging.
    Soares LC; de Souza RJ; Oliveira MAP
    Acta Obstet Gynecol Scand; 2023 Dec; 102(12):1757-1758. PubMed ID: 37592393
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of the 2023 FIGO Staging System for Endometrial Cancer on the Use of Imaging Services: An Indian Perspective.
    Chandramohan A; Manchanda S; Renganathan R; Popat PB; Shah D; Dhamija E; Sen A
    Indian J Radiol Imaging; 2024 Apr; 34(2):309-323. PubMed ID: 38549900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of pre-therapeutic imaging work-up in the staging of endometrial cancer: Interest in a systematic second opinion in a cancer center.
    Baijnath P; Pelissier M; Sahki N; Henrot P
    J Gynecol Obstet Hum Reprod; 2024 Feb; 53(2):102716. PubMed ID: 38142752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative MR evaluation of features that indicate the need of adjuvant therapies in early stage cervical cancer patients. A single-centre experience.
    Rizzo S; Calareso G; Maccagnoni S; Angileri SA; Landoni F; Raimondi S; Pasquali E; Lazzari R; Bellomi M
    Eur J Radiol; 2014 May; 83(5):858-64. PubMed ID: 24581810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late Radiation-Related Toxicities in Patients Treated for Early-Stage Cervical Carcinoma by Surgery and Adjuvant Radiotherapy: A Retrospective Imaging Study.
    Nadova K; Burghardtova M; Fejfarova K; Reginacova K; Malikova H
    Pathol Oncol Res; 2021; 27():1609915. PubMed ID: 34650341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Importance of Clinical Examination under General Anesthesia: Improving Parametrial Assessment in Cervical Cancer Patients.
    Sodeikat P; Lia M; Martin M; Horn LC; Höckel M; Aktas B; Wolf B
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34199156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume Delineation in Cervical Cancer With T2 and Diffusion-weighted MRI: Agreement on Volumes Between Observers.
    Rosa C; Pizzi AD; Augurio A; Caravatta L; DI Tommaso M; Mincuzzi E; Cinalli S; Basilico R; Porreca A; DI Nicola M; Genovesi D
    In Vivo; 2020; 34(4):1981-1986. PubMed ID: 32606170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ADC values in assessing clinical response and identifying residual disease post-chemo radiation in uterine cervix cancer.
    Jajodia A; Mahawar V; Chaturvedi AK; Rao A; Singla R; Mitra S; Goyal S; Kesan S; Pasricha S; Maheshwari U; Tripathi R; Babu Koyyala VP
    Indian J Radiol Imaging; 2019; 29(4):404-411. PubMed ID: 31949343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.